• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共刺激缺陷的抗原呈递诱导无反应性需要T细胞上的CD80与CD152结合。

CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.

作者信息

Chai J G, Vendetti S, Amofah E, Dyson J, Lechler R

机构信息

Department of Immunology, Imperial College School of Medicine, and Transplantation Biology Group, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, London, United Kingdom.

出版信息

J Immunol. 2000 Sep 15;165(6):3037-42. doi: 10.4049/jimmunol.165.6.3037.

DOI:10.4049/jimmunol.165.6.3037
PMID:10975813
Abstract

Two apparently contradictory observations have been made concerning peripheral T cell tolerance; costimulation-deficient Ag presentation leads to unresponsiveness, and CTLA4 (CD152) ligation is required for unresponsiveness to be induced. This issue was addressed using a CD80- CD86low B cell line to present Ag to DO.11.10 naive CD4+ T cells. Proliferation was substantially enhanced by anti-CD80 or anti-CD152, but was inhibited by anti-CD86. Furthermore, anti-CD80 partially, and anti-CD152 totally protected cloned DO.11.10 T cells from the induction of unresponsiveness following culture with peptide and Chinese hamster ovary H2-Ad+ CD80- CD86- cells. Fab of anti-CD80 caused similar enhancement, and coimmobilized anti-CD80 failed to costimulate the anti-CD3 response of purified T cells, indicating that direct signaling by anti-CD80 was not responsible for these effects. The possibility that anti-CD80 liberated CD28 molecules that were sequestered by the T cell-expressed CD80, enabling them to coaggregate with TCR:CD3 complexes was excluded by finding that anti-CD80 and anti-CD152 individually caused maximal enhancement, rather than having additive effects. These data suggest that T cell-expressed CD80 has a regulatory function and plays a key role in the induction of unresponsiveness due to costimulation-deficient Ag presentation by the ligation of CD152 on neighboring, or even the same, T cell.

摘要

关于外周T细胞耐受性,出现了两个明显相互矛盾的观察结果:共刺激缺陷的抗原呈递导致无反应性,且诱导无反应性需要CTLA4(CD152)的结合。使用CD80 - CD86低表达的B细胞系将抗原呈递给DO.11.10幼稚CD4 + T细胞来解决这个问题。抗CD80或抗CD152可显著增强增殖,但抗CD86则抑制增殖。此外,抗CD80部分地、抗CD152完全地保护克隆的DO.11.10 T细胞,使其在与肽和中国仓鼠卵巢H2 - Ad + CD80 - CD86 - 细胞共培养后不被诱导产生无反应性。抗CD80的Fab片段引起类似的增强作用,并且共固定的抗CD80不能共刺激纯化T细胞的抗CD3反应,这表明抗CD80的直接信号传导并非这些效应的原因。通过发现抗CD80和抗CD152单独引起最大增强作用而非具有累加效应,排除了抗CD80释放被T细胞表达的CD80隔离的CD28分子,使其能够与TCR:CD3复合物共聚集的可能性。这些数据表明,T细胞表达的CD80具有调节功能,并且在由于共刺激缺陷的抗原呈递通过邻近甚至同一T细胞上CD152的结合而诱导无反应性过程中起关键作用。

相似文献

1
CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.共刺激缺陷的抗原呈递诱导无反应性需要T细胞上的CD80与CD152结合。
J Immunol. 2000 Sep 15;165(6):3037-42. doi: 10.4049/jimmunol.165.6.3037.
2
Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.共刺激在体外激活初始抗原特异性TCR转基因CD8 + T细胞中的关键作用。
J Immunol. 1999 Aug 1;163(3):1298-305.
3
Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).使用与表面相连的抗CTLA-4(CD152)单链抗体阻断T细胞活化。
J Immunol. 2000 May 1;164(9):4433-42. doi: 10.4049/jimmunol.164.9.4433.
4
Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.CTLA-4(CD152)与CD80或CD86的相互作用会抑制人类T细胞的激活。
Immunology. 1999 Nov;98(3):413-21. doi: 10.1046/j.1365-2567.1999.00888.x.
5
Induction of T cell anergy in the absence of CTLA-4/B7 interaction.在不存在CTLA-4/B7相互作用的情况下诱导T细胞无能。
J Immunol. 2000 Mar 15;164(6):2987-93. doi: 10.4049/jimmunol.164.6.2987.
6
The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.CD28/CTLA-4-B7信号通路参与了对口服花生蛋白的过敏致敏和耐受诱导过程。
J Immunol. 2007 Jun 1;178(11):6894-900. doi: 10.4049/jimmunol.178.11.6894.
7
Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.共刺激信号:用CD80或CD86而非抗CD28激活CD4 + T细胞会导致Th2细胞因子谱。
J Immunol. 2000 Dec 15;165(12):6908-14. doi: 10.4049/jimmunol.165.12.6908.
8
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.共刺激分子CD80和CD86及其受体CD28、CTLA-4在卵巢癌及其他类型腹膜癌患者恶性腹水中CD3⁺肿瘤浸润淋巴细胞(TIL)上的表达。
Clin Exp Immunol. 2000 Jan;119(1):19-27. doi: 10.1046/j.1365-2249.2000.01105.x.
9
Characterization of human inducible costimulator ligand expression and function.人诱导共刺激配体的表达及功能特性
J Immunol. 2000 May 1;164(9):4689-96. doi: 10.4049/jimmunol.164.9.4689.
10
Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.在胶原诱导性关节炎中对CD28、CD80、CD86或CD152的干扰。干扰素-γ在抗B7介导的疾病抑制中的作用有限。
J Autoimmun. 2001 Aug;17(1):39-50. doi: 10.1006/jaut.2001.0527.

引用本文的文献

1
Activation of T cell checkpoint pathways during β-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes.工程化树突状细胞在β细胞抗原呈递过程中激活 T 细胞检查点途径可促进 1 型糖尿病的保护。
Immunology. 2022 Jul;166(3):341-356. doi: 10.1111/imm.13476. Epub 2022 Apr 22.
2
Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance.工程化树突状细胞定向同时激活多条 T 细胞抑制途径诱导强大的免疫耐受。
Sci Rep. 2019 Aug 19;9(1):12065. doi: 10.1038/s41598-019-48464-y.
3
Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions.
RhuDex®对B7-1(CD80)的抑制作用可减轻人动脉粥样硬化病变中脂多糖介导的炎症。
Drug Des Devel Ther. 2014 May 12;8:447-57. doi: 10.2147/DDDT.S59594. eCollection 2014.
4
Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell.CTLA-4 通过激活 Hippo 通路调节 CD8+T 细胞中 Blimp-1 的表达。
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):E2223-9. doi: 10.1073/pnas.1209115109. Epub 2012 Jun 27.
5
Long-term control of alloreactive B cell responses by the suppression of T cell help.通过抑制T细胞辅助实现同种反应性B细胞反应的长期控制。
J Immunol. 2008 May 1;180(9):6077-84. doi: 10.4049/jimmunol.180.9.6077.
6
Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.定点体外免疫产生一种完全人源单克隆IgG4λ,其特异性结合CTLA-4(CD152)的CDR2区域,而不干扰天然配体的结合。
BMC Biotechnol. 2007 Aug 23;7:51. doi: 10.1186/1472-6750-7-51.
7
CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.CD4+ CD25+ 调节性T细胞抑制CD4+ T细胞功能,并抑制参与脑型疟发病机制的伯氏疟原虫特异性TH1反应的发展。
Infect Immun. 2007 May;75(5):2275-82. doi: 10.1128/IAI.01783-06. Epub 2007 Feb 26.
8
Expression of class I MHC molecule, HSP70 and TAP in human hepatocellular carcinoma.人肝细胞癌中I类主要组织相容性复合体分子、热休克蛋白70及抗原加工相关转运体的表达
World J Gastroenterol. 2003 Aug;9(8):1853-5. doi: 10.3748/wjg.v9.i8.1853.
9
Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance.给予外源性白细胞介素-18和白细胞介素-12可阻止口服耐受的诱导。
Immunology. 2003 Feb;108(2):196-203. doi: 10.1046/j.1365-2567.2003.01570.x.